Robert Clarke, Jane Armitage, Sarah Lewington, Rory Collins, Jackie Bosch: Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. In: JAMA Cardiology. Band3, Nr.3, 1. März 2018, S.225–233, doi:10.1001/jamacardio.2017.5205 (jamanetwork.com [abgerufen am 7. Mai 2019]).
J. T. Brenna, N. Salem, A. J. Sinclair, S. C. Cunnane: alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. In: Prostaglandins, leukotrienes, and essential fatty acids. Band 80, Nummer 2–3, Feb-Mar 2009, S. 85–91. doi:10.1016/j.plefa.2009.01.004. PMID 19269799. (Review).
Breanne M Anderson, David WL Ma: Are all n-3 polyunsaturated fatty acids created equal? In: Lipids in Health and Disease. 8, 2009, S. 33, doi:10.1186/1476-511X-8-33.
M. M. Rogero, P. C. Calder: Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. In: Nutrients. Band10, 2018, doi:10.3390/nu10040432, PMID 29601492, PMC 5946217 (freier Volltext) – (englisch).
Robert Clarke, Jane Armitage, Sarah Lewington, Rory Collins, Jackie Bosch: Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. In: JAMA Cardiology. Band3, Nr.3, 1. März 2018, S.225–233, doi:10.1001/jamacardio.2017.5205 (jamanetwork.com [abgerufen am 7. Mai 2019]).
merckmillipore.com
Datenblatt Eicosapentaenoic Acid (PDF) bei Calbiochem, abgerufen am 8. Dezember 2015.
nih.gov
ncbi.nlm.nih.gov
J. T. Brenna, N. Salem, A. J. Sinclair, S. C. Cunnane: alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. In: Prostaglandins, leukotrienes, and essential fatty acids. Band 80, Nummer 2–3, Feb-Mar 2009, S. 85–91. doi:10.1016/j.plefa.2009.01.004. PMID 19269799. (Review).
J. T. Brenna: Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. In: Current opinion in clinical nutrition and metabolic care. Band 5, Nummer 2, März 2002, S. 127–132. PMID 11844977.
E. Mantzioris, M. J. James, R. A. Gibson, L. G. Cleland: Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. In: The American journal of clinical nutrition. Band 59, Nummer 6, Juni 1994, S. 1304–1309. PMID 7910999.
M. M. Rogero, P. C. Calder: Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. In: Nutrients. Band10, 2018, doi:10.3390/nu10040432, PMID 29601492, PMC 5946217 (freier Volltext) – (englisch).
P. Adams, S. Lawson u. a.: Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. In: Lipids. Nr.31, 1996, S.157–161.PMID 8729112.
V. K. Burt, L. L. Altshuler u. a.: Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment. In: Harvard Review of Psychiatry. Nr.6(3), 1998, S.121–132, PMID 10372280.
M. Peet, J. Brind, C. N. Ramchand, S. Shah, G. K. Vankar: Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. In: Schizophr. Res. Band49, Nr.3, 2001, S.243–251, PMID 11356585 (englisch, ucla.edu [PDF]).
C. Song, S. Zhao: Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations. In: Expert Opin Investig Drugs. 16(10), Okt 2007, S. 1627–1638. PMID 17922626.
Julian G. Martens: EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. In: Journal of the American College of Nutrition. 28, 2009, S. 525–542. PMID 20439549 (Review).
M. Peet, J. Brind, C. N. Ramchand, S. Shah, G. K. Vankar: Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. In: Schizophr. Res. Band49, Nr.3, 2001, S.243–251, PMID 11356585 (englisch, ucla.edu [PDF]).